Sign in
CompletedNo phase

Ketogenic Diet & Functional Recovery in Moderate to Severe Traumatic Brain Injury

Key facts

Who runs it
Loma Linda University
Where
Loma Linda, United StatesSee the site
Trial code
Status
Completed
People taking part
21 people enrolled
Started
7 Dec 2020
Ended
14 Aug 2025
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • ketogenic/modified Atkins diet
  • Standard diet
Record updated
4 February 2026

Who can take part

Age
16 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • complicated mild (GCS 13-15), moderate (GCS 9 - 12) to severe (GCS ≤ 8) traumatic brain injury (TBI) between 2-30 days post injury
  • Admitted to Loma Linda University surgical intensive care unit (SICU)

Who cannot take part

  • abdominal surgery during the same admission
  • history of comorbid ischemic stroke following qualifying TBI
  • history of premorbid brain injury with associated loss of consciousness
  • history of psychiatric disorder
  • history of premorbid neurological disorder or neurosurgical intervention
  • acute renal failure according to the Risk, Injury, Failure, Loss of kidney function, and End-stage kidenty disease (RIFLE) classification
  • type 1 diabetes
  • known history of metabolic disorders that are a contradiction for ketogenic diet (KD) such as primary carnitine deficient, carnitine palmitoyltransferase (CPT) I or II deficiency, carnitine translocase deficiency, beta-oxidation defects, pyruvate carboxylase deficiency, or porphyria
  • prealbumin (transthyretin) levels of <10 mg/dL within 3 days of admission
  • pregnancy
  • depressed GCS score due to acute intoxication
  • liver dysfunction as defined by liver enzymes 5 times the upper limit of normal or chronic cirrhosis
  • gastroparesis
  • dyslipidemia
  • severe asphasia
  • Metal, implanted device (ICP monitor), pregnancy, claustrophobia, or other contraindication to MRI

Where in United States

  • Loma Linda University HealthLoma Linda, United States

About the trial

What the trial wants to find out

Traumatic Brain Injury (TBI) represents a significant public health risk in the United States leaving many survivors with significant long term cognitive deficits and at risk for neurodegenerative diseases. Despite extensive research there are no pharmacological therapies which have demonstrated significant improvement in neurological or cognitive recovery. Changes in glucose metabolism are considered the hallmark metabolic response to TBI and ketosis has been proposed as a therapy to ameliorate metabolic dysfunction. This trial investigates the therapeutic potential of a ketogenic or modified Atkins diet on neurocognitive outcome following moderate-severe TBI.

The 2 groups in the trial

  • TBI KD/MADTreatment being tested

    TBI subjects on a ketogenic/modified Atkins diet

    Treatment: ketogenic/modified Atkins diet

  • TBI SDSham treatment, for comparison

    TBI subjects on a standard (normal) diet

    Treatment: Standard diet

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
4 February 2026